HLS Therapeutics Inc.

HLS on TSXToday's ChangeVolume52 Week Range (Low/Hi)Market Cap
18.57CAN 1.36%33,59413.35 - 21.89589.484M

Contact Information

HLS Therapeutics Inc.

Headquarters:
10 Carlson Court, Suite 701
Etobicoke, Ontario
Canada, M9W 6L2
Tel: 1-647-495-9000
Fax: 416-213-0045
Email: Send a message
Website: Visit website
For more information...
Lead: Scott Logan

HLS Therapeutics Inc. (TSX:HLS) is a specialty pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial-stage promoted and established branded pharmaceutical products in the North American markets. We focus on products targeting the central nervous system and cardiovascular therapeutic areas. Our management team is comprised of seasoned pharmaceutical executives with a strong track record of success in these therapeutic areas and at managing products in each of these lifecycle stages.

HLS Therapeutics focuses on the North American market and has operational locations in Toronto (Etobicoke, Ontario), Montreal (Dorval, Quebec) and Philadelphia (Rosemont, Pennsylvania).  We source our products from the drug’s originator or from best-in-class manufacturing partners, ensuring our brands are manufactured with the highest standards of quality and in compliance with FDA and Health Canada’s regulations.

Bill Wells, BA, MBA - Executive Chairman of the Board

Gilbert Godin , BEng, MBA - Chief Executive Officer

Tim Hendrickson, MBA - Chief Financial Officer

Hemanth Varghese, PhD - Head of Corporate Strategy and Business Development

Ryan C. Lennox BA, JD - General Counsel

Sanjiv Sharma, MBA - Chief Commercial Officer

Jason A. Gross, PharmD - VP Scientific Affairs

Bill Wells, BA, MBA - Executive Chairman of the Board

Gilbert Godin , BEng, MBA - Chief Executive Officer

Greg Gubitz, BA, LLB - Director

J. Spencer Lanthier - Director, Independent

Yvon Bastien - Director, Independent

Laura A. Brege - Director, Independent

Don DeGolyer - Director, Independent

Rodney Hill - Director, Independent

Stock Information

Events

Mar 19, 2021 - 11:00 AM EDT Corporate Presentation - Toronto

Company Overview

HLS Therapeutics Inc. (TSX:HLS) is a specialty pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial-stage promoted and established branded pharmaceutical products in the North American markets. We focus on products targeting the central nervous system and cardiovascular therapeutic areas. Our management team is comprised of seasoned pharmaceutical executives with a strong track record of success in these therapeutic areas and at managing products in each of these lifecycle stages.

HLS Therapeutics focuses on the North American market and has operational locations in Toronto (Etobicoke, Ontario), Montreal (Dorval, Quebec) and Philadelphia (Rosemont, Pennsylvania).  We source our products from the drug’s originator or from best-in-class manufacturing partners, ensuring our brands are manufactured with the highest standards of quality and in compliance with FDA and Health Canada’s regulations.

Management

Bill Wells, BA, MBA - Executive Chairman of the Board

Gilbert Godin , BEng, MBA - Chief Executive Officer

Tim Hendrickson, MBA - Chief Financial Officer

Hemanth Varghese, PhD - Head of Corporate Strategy and Business Development

Ryan C. Lennox BA, JD - General Counsel

Sanjiv Sharma, MBA - Chief Commercial Officer

Jason A. Gross, PharmD - VP Scientific Affairs

Board of Directors

Bill Wells, BA, MBA - Executive Chairman of the Board

Gilbert Godin , BEng, MBA - Chief Executive Officer

Greg Gubitz, BA, LLB - Director

J. Spencer Lanthier - Director, Independent

Yvon Bastien - Director, Independent

Laura A. Brege - Director, Independent

Don DeGolyer - Director, Independent

Rodney Hill - Director, Independent

Contact Information

Headquarters:
10 Carlson Court, Suite 701
Etobicoke, Ontario
M9W 6L2, Canada
Telephone: 1-647-495-9000
Fax: 416-213-0045
Email: Send a message
Website: Visit website